サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1208608

口蹄疫ワクチンの世界市場-2023-2030

Global Foot and Mouth Disease Vaccines Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
口蹄疫ワクチンの世界市場-2023-2030
出版日: 2023年02月01日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の口蹄疫ワクチンの市場規模は、2023年には28億7430万米ドルで、予測期間（2023～2030年）にCAGR8.6％で成長するとされています。

DNA検査は、しばしば遺伝子検査として知られ、ヒトの遺伝子、染色体、またはタンパク質の変化を発見することができる医療検査です。これらの変異は、人が遺伝性疾患を患っているか否かを明らかにすることができます。DNA検査は、特定の病気に罹患するリスクや、遺伝的な問題を引き継ぐリスクも決定することができます。DNAの検査は任意です。検査には利点があり、欠点やリスクがあるため、検査を受けるかどうかは、複雑で個人的なものです。遺伝学者や遺伝カウンセラーは、検査の長所と短所を概説し、社会的・感情的な影響を調べることで支援することができます。

市場力学

世界の口蹄疫ワクチン市場を牽引する主な要因は、世界の動物製品の需要増加、積極的な政府プロジェクト、研究開発費の増加、世界の動物人口の増加に伴い口蹄疫ワクチン市場が発展すること、などです。

畜産物に対する世界の需要の高まりは、市場の成長を促進すると予想されます。

牛乳、鶏肉、卵、繊維、ハイテク機械などの畜産物に対する需要の高まりは、畜産ビジネスを変化させ、大規模な投資を誘致する要因となっています。動物の損失を減らすために使われる主な戦略の1つはワクチン接種です。政府や民間の動物会社のオーナーは、感染した動物を死なせてしまうと、大きな経済的損失を被る危険性があります。永久的な治療法がないことと、汚染が起こる可能性が数多くあることから、FMDワクチンは不可欠です。

肉食の問題は、2022年半ばに世界中で経験した異常な気候現象、特に記録的な高温とロシアのウクライナ侵攻によってもたらされたエネルギー危機によって浮上しました。2022年に医学誌『ランセット』に掲載された英国における食肉の動向に関する論文によると、一人当たりの平均消費量と総消費量は世界的に増加しています。この急増の原因として、人口の拡大、富の増加、肉を食べることに価値を置く社会文化的規範などが挙げられています。

記事によると、「肉の消費と減肉に対する考え方は、年齢、性別、民族性、収入によって特徴づけられるように、人口のセグメントによって異なる」そうです。記事はさらに、肉の消費における不平等が、国の中にも存在することを強調しています。国連食糧農業機関（FAO）の最新の食料見通し調査では、動物の病気の蔓延、紛争、投入コストの上昇を特徴とする厳しい生産環境にもかかわらず、2022年の世界の食肉生産量は緩やかに増加すると予測されています。

高価なコストは、市場の成長を妨げると予想されます。

しかし、高いワクチン保管コストが市場拡大を抑制すると予想されます。

COVID-19の影響分析

2019年12月のCOVID-19ウイルス流行以来、この病気は100カ国以上に広がり、2020年1月30日、世界保健機関は公衆衛生上の緊急事態を宣言しました。COVID-19が経済に与える主な影響としては、他の医薬品やワクチンの需給に直接影響を与えること、流通システムに混乱をもたらすこと、メーカーに経済的影響を与えることの3点が挙げられます。中国、インド、サウジアラビア、アラブ首長国連邦、エジプトなど多くの国では、広範囲に及ぶ封鎖により、ある場所から別の場所へ医薬品を移動することが困難になっています。

しかし、COVID-19のパンデミックは、業界の大手企業が動物を保護できるCOVID-19（コロナウイルス）ワクチンを作るために価値あるチャンスをつかんでいるので、口蹄疫予防接種の世界市場に害を及ぼしています。例えば、2020年4月、中国のバイオ製薬会社シノバク・バイオテック社の科学者は、同社のCOVID-19ワクチンを8匹のアカゲザルに2回投与しました。COVID-19ウイルスは3週間後、サルの気管を通る管を通して肺に挿入されたが、本格的な感染症を発症した者はいなかっています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 世界の畜産物の需要増加
      • 積極的な政府プロジェクト
    • 抑制要因
      • 高価なコストが市場の成長を妨げると予想されます。
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 従来型ワクチン
  • 緊急用ワクチン

第8章 動物タイプ別

  • 牛
  • ヤギ
  • 豚
  • ヒツジ
  • その他

第9章 流通チャネル別

  • 動物病院
  • ペットクリニック

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Boehringer Ingelheim International GmbH
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Merck and Co., Inc
  • China Agricultural Vet. Bio. Science and Technology
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd
  • Vecol S.A.
  • Brilliant Bio Pharma Private Limited
  • Limor de Colombia
  • FGBI-ARRIAH
  • QYH Biotech.

第13章 世界の口蹄疫ワクチン市場-DataM

目次
Product Code: DMVH1523

Market Overview

The global foot and mouth disease vaccines market size was valued at US$ 2,874.3 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 8.6% during the forecast period (2023-2030).

A DNA test, often known as genetic testing, is a medical examination that can spot changes in human genes, chromosomes, or proteins. These mutations can reveal if a person has a genetic disorder or not. DNA tests can also determine a person's risk of contracting a certain illness or passing along a genetic problem. Testing for DNA is optional. Whether to be tested is complex and personal because there are advantages to testing and drawbacks and risks. A geneticist or genetic counselor can assist by outlining the advantages and disadvantages of the test and by going over its social and emotional implications.

Market Dynamics

The major factors driving the global foot and mouth disease vaccines market the the rise in the global demand for animal products, positive governmental projects, increasing research and development spending, and the foot and mouth disease vaccine market will develop as the animal population increases globally.

The rise in the global demand for animal products is expected to drive the market's growth.

The growing demand for animal goods, including milk, chicken, eggs, mefabrics, andl as high-tech machinery, are some drivers changing the animal business and luring massive investment. One of the main strategies used to reduce animal loss is vaccination. Governments and private animal company owners risk suffering significant financial losses if affected animals are put to death. Due to the lack of a permanent treatment and the numerous ways in which contamination might happen, the FMD vaccine is essential.

The issue of meat eating has come up due to the extraordinary climatic occurrences experienced around the world in mid-2022, most notably record-high temperatures and the energy crisis brought on by Russia's invasion of Ukraine. According to a 2022 article on meat trends in the U.K. published in the medical journal The Lancet, the average quantity of meat consumed per person and the total amount consumed is increasing globally. Population expansion increased wealth, and sociocultural norms that place a high value on eating meat are all blamed for this surge.

According to the article, "attitudes towards meat consumption and meat reduction differ within segments of the population, as characterized by age, gender, ethnicity, or income." The article goes on to underline that inequalities in meat consumption also exist within countries. The newest Food Outlook study from the U.N. Food and Agriculture Organization (FAO) predicts that global meat output will increase moderately in 2022, despite a difficult production environment characterized by widespread animal illnesses, conflicts, and rising input costs.

Expensive cost is expected to hamper the market's growth.

However, high vaccine storage costs are anticipated to restrain market expansion.

COVID-19 Impact Analysis

The disease has spread to over 100 nations since the COVID-19 viral epidemic in December 2019, and on January 30, 2020, the World Health Organization proclaimed it a public health emergency. The three primary ways that COVID-19 can affect the economy include directly impacting the supply and demand for other medications and vaccines, causing disruptions in the distribution system, and having an economic impact on manufacturers. Many nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, have difficulty moving pharmaceuticals from one location to another due to widespread lockdowns.

The COVID-19 pandemic, however, harms the global market for foot and mouth disease vaccinations since major firms in the industry are grabbing value-grab chances to create COVID-19 (coronavirus) vaccines that can protect animals. For instance, in April 2020, scientists from the Chinese biopharmaceutical company Sinovac Biotech Ltd. administered two doses of its COVID-19 vaccine to eight rhesus macaques. The COVID-19 virus was inserted into the monkeys' lungs through tubes down their tracheas three weeks later, but none developed a full-blown infection.

Segment Analysis

The cattle segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The animal type segment is the highest market holder in the global foot and mouth disease vaccines market. The huge population of cattle worldwide and the domination of cattle farming as a major source of income for people in many nations are the main causes of the rise of the livestock segment. For instance, the likelihood of contracting an infection would be higher in nations with big cattle populations, such as China and Mexico. The Food and Agriculture Organization (FAO) predicted in September 2021 that India's national herd would increase by 1.2 million head from the Italy cattle count in 2021 to reach 306.7 million animals in 2022.

One of the most contagious illnesses in cattle is FMD. It threatens the world's cow population and has resulted in significant financial losses. Although this disease was successfully eradicated in the U.S. in 1929, several other nations are currently engaged in this conflict. The market growth may be boosted by OIE (World Organization for Animal Health) campaigns like the Southeast Asia Foot and Mouth Disease Campaign (SEAFMDC).

The introduction of immunization programs for cattle by various organizations is also anticipated to fuel the segment's expansion. For instance, the Prayagraj animal husbandry began a huge campaign to immunize cows and other cattle against foot and mouth disease in August 2020. Due to the rising demand for better and healthier meat, there is growing awareness of zoonoses and diseases affecting cattle. Therefore, these variables will have a favorable impact on the market in the years to come.

Geographical Analysis

North America holds the largest market share in the global Foot And Mouth Disease Vaccines market.

North America dominates the global foot and mouth disease vaccines market primarily due to excellent medical infrastructure, and high-income levels. Due to the widespread implementation of benefits for animal healthcare in the region, the North American region is one of the largest contributors to the vaccine market against foot and mouth disease. A combination of sophisticated animal healthcare programs and increased public awareness of animal health is expected to fuel the market's rapid growth in the region.

Additionally, the prevalence of animal diseases is driving up the demand for quick and efficient treatment alternatives, which is anticipated to drive the market's growth over the forecast period. For instance, it was indicated in the December 2021 article titled "Foreign animal disease concern: foot and mouth disease" that foot and mouth disease was a condition that needed to be reported in the United States. Foot and mouth disease decimates the cattle business in the U.S. and results in catastrophic losses that harm the economy and animal welfare. Foot and mouth disease's impact on animal welfare is anticipated to increase demand for efficient immunization.

Additionally, it is anticipated that several market players will continue to create new products, fueling the market's expansion in this area. To permit the production of the foot and mouth disease vaccine in the United States, for instance, Zoetis, Inc. submitted a petition to the Animal and Plant Health Inspection Services in August 2020. Thus, it is anticipated that the abovementioned elements will fuel market expansion in this area during the projection year.

Competitive Landscape

The foot and mouth disease vaccines market is moderately competitive with local and global companies' presence. Boehringer Ingelheim International GmbH, Merck and Co., Inc, China Agricultural Vet. Bio. Science and Technology, Biogenesis Bago SA, Indian Immunologicals Ltd

Vecol S.A., Brilliant Bio Pharma Private Limited, Limor de Colombia, FGBI-ARRIAH, QYH Biotech and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022,a new animal vaccine production plant is being built in Hyderabad by Indian Immunologicals (IIL), a division of the National Dairy Development Board (NDDB), with an investment of Rs 700 crore. The facility's ability to produce 600 million annual doses of the Foot and Mouth disease (FMD) vaccine will be doubled.

Boehringer Ingelheim International GmbH.

Overview: A division of CH Boehringer Sohn AG & Co KG, Boehringer Ingelheim International GmbH (Boehringer) is a pharmaceutical firm that develops, produces, and sells medicines, parasiticides, vaccines, and therapies for unmet medical needs. It provides a wide range of products, including biopharmaceuticals, animal health care items, and treatments for human ailments. The company's medications are used, among other things, to treat diseases of the immune system, the cardiovascular and metabolic systems, the respiratory system, cancer, and the retina. Additionally, it provides animal healthcare items for pigs, ruminants, poultry, horses, and other species.

Product Portfolio:

Aftopor: Aftopor, Aftovaxpur, and Aftobov Oleosa, three FMD vaccines with highly powerful and purified antigens, may offer marker features that allow difference between infected and vaccinated animals (DIVA) for endemic or emergency situations. Only use Aftovaxpur Doe in dire circumstances.

The global Foot And Mouth Disease Vaccines market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the global demand for animal products
      • 4.1.1.2. Positive governmental projects.
    • 4.1.2. Restraints:
      • 4.1.2.1. Expensive cost is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Conventional Vaccines
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Emergency Vaccines

8. By Animal Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 8.1.2. Market Attractiveness Index, By Animal Type
  • 8.2. Cattle
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Goat
  • 8.4. Pig
  • 8.5. Sheep
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Veterinary Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pet Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Boehringer Ingelheim International GmbH
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Merck and Co., Inc
  • 12.3. China Agricultural Vet. Bio. Science and Technology
  • 12.4. Biogenesis Bago SA
  • 12.5. Indian Immunologicals Ltd
  • 12.6. Vecol S.A.
  • 12.7. Brilliant Bio Pharma Private Limited
  • 12.8. Limor de Colombia
  • 12.9. FGBI-ARRIAH
  • 12.10. QYH Biotech.

LIST NOT EXHAUSTIVE

13. Global Foot And Mouth Disease Vaccines Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us